Literature DB >> 15860804

Radiotherapy for the future.

Bleddyn Jones, Neil Burnet.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15860804      PMCID: PMC557134          DOI: 10.1136/bmj.330.7498.979

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  11 in total

1.  Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.

Authors:  Antony J Lomax; Laura Cella; Damien Weber; John M Kurtz; Raymond Miralbell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

2.  Particle Therapy Co-operative Oncology Group (PTCOG 40) meeting, Institute Curie 2004.

Authors:  B Jones; I Rosenberg
Journal:  Br J Radiol       Date:  2005-02       Impact factor: 3.039

3.  Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.

Authors:  Brigitta G Baumert; Ian A Norton; Antony J Lomax; J Bernard Davis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

4.  Effect of heavy-ion radiotherapy on pulmonary function in stage I non-small cell lung cancer patients.

Authors:  Kennosuke Kadono; Toshiaki Homma; Kazuyuki Kamahara; Mika Nakayama; Hiroaki Satoh; Kiyohisa Sekizawa; Tadaaki Miyamoto
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

5.  Effects of proton and combined proton/photon beam radiation on pulmonary function in patients with resectable but medically inoperable non-small cell lung cancer.

Authors:  R B Bonnet; D Bush; G A Cheek; J D Slater; D Panossian; C Franke; J M Slater
Journal:  Chest       Date:  2001-12       Impact factor: 9.410

6.  A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.

Authors:  L Cozzi; A Fogliata; A Lomax; A Bolsi
Journal:  Radiother Oncol       Date:  2001-12       Impact factor: 6.280

7.  Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.

Authors:  Tadashi Kamada; Hirohiko Tsujii; Hiroshi Tsuji; Tsuyoshi Yanagi; Jun-etsu Mizoe; Tadaaki Miyamoto; Hirotoshi Kato; Shigeru Yamada; Shinroku Morita; Kyousan Yoshikawa; Susumu Kandatsu; Akio Tateishi
Journal:  J Clin Oncol       Date:  2002-11-15       Impact factor: 44.544

8.  Proton-beam radiotherapy for early-stage lung cancer.

Authors:  D A Bush; J D Slater; R Bonnet; G A Cheek; R D Dunbar; M Moyers; J M Slater
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

9.  Carbon ion radiotherapy for stage I non-small cell lung cancer.

Authors:  Tadaaki Miyamoto; Naoyoshi Yamamoto; Hideki Nishimura; Masashi Koto; Hirohiko Tsujii; Jun-etsu Mizoe; Tadashi Kamada; Hirotoshi Kato; Shigeru Yamada; Shinroku Morita; Kyosan Yoshikawa; Susumu Kandatsu; Takehiko Fujisawa
Journal:  Radiother Oncol       Date:  2003-02       Impact factor: 6.280

10.  Results of carbon ion radiotherapy in 152 patients.

Authors:  Daniela Schulz-Ertner; Anna Nikoghosyan; Christoph Thilmann; Thomas Haberer; Oliver Jäkel; Christian Karger; Gerhard Kraft; Michael Wannenmacher; Jürgen Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-02-01       Impact factor: 7.038

View more
  4 in total

1.  Waiting for radiotherapy.

Authors:  D Dodwell; A Crellin
Journal:  BMJ       Date:  2006-01-14

2.  Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment.

Authors:  Xiaodong Zhang; Lei Dong; Andrew K Lee; James D Cox; Deborah A Kuban; Ron X Zhu; Xiaochun Wang; Yupeng Li; Wayne D Newhauser; Michael Gillin; Radhe Mohan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-01       Impact factor: 7.038

3.  Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer.

Authors:  Zhouguang Hui; Xiaodong Zhang; George Starkschall; Yupeng Li; Radhe Mohan; Ritsuko Komaki; James D Cox; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-15       Impact factor: 7.038

4.  Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk.

Authors:  Steve Braunstein; Jean L Nakamura
Journal:  Front Oncol       Date:  2013-04-03       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.